Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Microbial Immunity and Vaccines

Salmonella enterica Serovar Typhi Live Vector Vaccines Delivered Intranasally Elicit Regional and Systemic Specific CD8+ Major Histocompatibility Class I-Restricted Cytotoxic T Lymphocytes

Marcela F. Pasetti, Rosangela Salerno-Gonçalves, Marcelo B. Sztein
Marcela F. Pasetti
1Center for Vaccine Development, Department of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mpasetti@medicine.umaryland.edu
Rosangela Salerno-Gonçalves
1Center for Vaccine Development, Department of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo B. Sztein
1Center for Vaccine Development, Department of Pediatrics
2Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.70.8.4009-4018.2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Surface expression of Salmonella serovar Typhi antigens on infected splenocytes and cell lines. Splenocytes from BALB/c (H-2d) and C57BL/6 (H-2b) mice and MHC-matched cell lines P815 (H-2d) and EL4 (H-2b) were infected in vitro with Salmonella serovar Typhi strain ISP1820 as described in Materials and Methods. Mock-infected cells were included as controls. Surface expression of bacterial antigens was measured in infected and mock-infected cells by multicolor flow cytometry by using FITC-conjugated anti-Salmonella CSA-1 antibodies. Cells were also incubated with FITC-labeled isotype control antibodies to determine nonspecific staining. Expression of bacterial antigens in BALB/c splenocytes was analyzed in the total cell population or gated on a particular cell phenotype (i.e., CD4+, CD8+, B220+, and CD11b+), as indicated. The percentage of specific staining is shown on each histogram. The data are representative of the data from four separate experiments in which similar results were obtained.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Detection of Salmonella serovar Typhi-specific CTL responses in mice immunized i.n. with attenuated Salmonella serovar Typhi vaccine strains. BALB/c mice were immunized i.n. with two doses (28 days apart) of Salmonella serovar Typhi vaccine strains Ty21a, CVD 915, CVD 908, and CVD 908-htrA or PBS (control) as described in Materials and Methods. Spleens and CLN were collected 56 to 60 days after the primary immunization. Effector cells were stimulated in vitro for 7 days with Salmonella serovar Typhi-infected syngeneic splenocytes in the presence of IL-7 and IL-2 and assayed for CTL activity against Salmonella serovar Typhi-infected and mock-infected P815 cells in 51Cr release assays. (A) CTL responses in splenocytes from mice inoculated with different vaccine strains or PBS (control). (B) CTL responses in CLN and spleens of mice that received CVD 908-htrA. All curves show the mean percentages of specific cytotoxicity at different E/T ratios for triplicate or quadruplicate wells; the error bars indicate standard deviations. The percentage of background lysis of mock-infected P815 target cells was subtracted from the percentage of Salmonella serovar Typhi-infected P815 lysis. The data are representative of the data from two complete, separate experiments in which similar results were obtained.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    In vitro expansion of CTL effectors with Salmonella serovar Typhi-infected cells is required to detect cytotoxic activity. Splenocytes from mice immunized with Salmonella serovar Typhi strains CVD 908-htrA and CVD 915 were examined for CTL activity without expansion, after in vitro expansion for 7 days in the presence of Salmonella serovar Typhi-infected syngeneic splenocytes, or after two consecutive rounds of expansion for a total of 14 days. The curves show the mean percentages of specific cytotoxicity for replicate wells; the error bars indicate standard deviations. The data are representative of the data from four different experiments in which similar results were obtained.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Increased proportion of CD8+ T cells in effector cell populations after expansion with Salmonella serovar Typhi-infected cells. The distribution of CD4+ and CD8+ T cells was measured by flow cytometry for splenocytes from immunized mice before and after expansion in the presence of Salmonella serovar Typhi-infected cells. The data are representative of the data from two complete, separate experiments in which similar results were obtained.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Cytotoxic activity is mediated by CD8+ T cells. CD4+ and CD8+ T cells sorted by flow cytometry from expanded splenocyte cultures from mice immunized with the different vaccine strains were assayed for cytotoxicity in the presence of Salmonella serovar Typhi-infected and mock-infected targets. The purity of sorted populations in different experiments was between 92 and 98%. No CTL activity was observed in PBS (control) mice. The curves show the mean percentages of specific cytotoxicity for replicate wells; the error bars indicate standard deviations. The data are representative of the data from two complete, separate experiments in which similar results were obtained.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    CTL activity is mediated by CD8+ αβ+. Splenocytes from immunized mice were phenotypically evaluated for expression of CD4, CD8, TCRαβ, TCRγδ, CD3, and NK markers before and after expansion with Salmonella serovar Typhi-infected cells by multicolor flow cytometry. The values represent the percentages of positive cells in each quadrant. The percentages of CD4+ and CD8+ cells within the NK-T cell population (CD3+ DX5+) are also shown. The data are representative of the data from four different experiments performed with effector cells from mice immunized with CVD 908-htrA. PE, phycoerythrin.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    CTL responses in spleens and CLN are MHC restricted. Effector cells from CLN and spleens of mice immunized with CVD 908-htrA were expanded for 7 days or 14 days (two rounds of 7 days each) and tested for cytotoxic activity in the presence of Salmonella serovar Typhi-infected and mock-infected MHC-matched P815 cells and mismatched EL4 cells. The curves show the mean percentages of specific cytotoxicity for replicate wells; the error bars indicate standard deviations. The data are representative of the data from three separate experiments in which similar results were obtained.

  • FIG. 8.
    • Open in new tab
    • Download powerpoint
    FIG. 8.

    Inhibition of CTL activity by MAbs to MHC class I molecules. Salmonella serovar Typhi-infected target cells were treated with medium (No Ab), an isotype control, or MAbs to the class I molecules H-2Dd, Qa-1b, H-2Kd, and H-2Ld, and CTL assays were performed. Effector cells had been expanded in vitro with Salmonella serovar Typhi-infected splenocytes for 7 or 14 days. The curves show the mean percentages of specific cytotoxicity for replicate wells; the error bars indicate standard deviations. The data are representative of the data for mice immunized with CVD 908-htrA in three separate experiments.

PreviousNext
Back to top
Download PDF
Citation Tools
Salmonella enterica Serovar Typhi Live Vector Vaccines Delivered Intranasally Elicit Regional and Systemic Specific CD8+ Major Histocompatibility Class I-Restricted Cytotoxic T Lymphocytes
Marcela F. Pasetti, Rosangela Salerno-Gonçalves, Marcelo B. Sztein
Infection and Immunity Aug 2002, 70 (8) 4009-4018; DOI: 10.1128/IAI.70.8.4009-4018.2002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Salmonella enterica Serovar Typhi Live Vector Vaccines Delivered Intranasally Elicit Regional and Systemic Specific CD8+ Major Histocompatibility Class I-Restricted Cytotoxic T Lymphocytes
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Salmonella enterica Serovar Typhi Live Vector Vaccines Delivered Intranasally Elicit Regional and Systemic Specific CD8+ Major Histocompatibility Class I-Restricted Cytotoxic T Lymphocytes
Marcela F. Pasetti, Rosangela Salerno-Gonçalves, Marcelo B. Sztein
Infection and Immunity Aug 2002, 70 (8) 4009-4018; DOI: 10.1128/IAI.70.8.4009-4018.2002
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Histocompatibility Antigens Class I
T-Lymphocytes, Cytotoxic
typhoid fever
Typhoid-Paratyphoid Vaccines
Vaccines, Synthetic

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522